Continuous Blood Sampling in Small Animal Positron Emission Tomography/Computed Tomography Enables the Measurement of the Arterial Input Function
August 8th, 2019
9.5K views
Here a protocol for continuous blood sampling during PET/CT imaging of rats to measure the arterial input function (AIF) is described. The catheterization, the calibration and setup of the system and the data analysis of the blood radioactivity are demonstrated. The generated data provide input parameters for subsequent bio-kinetic modeling.
Overview
This article presents a protocol for continuous blood sampling during PET/CT imaging in rats, aimed at measuring the arterial input function (AIF). The procedure includes catheterization, system calibration, and data analysis of blood radioactivity, which are crucial for bio-kinetic modeling.
Key Study Components
Area of Science
- Neuroscience
- Imaging Techniques
- Pharmacokinetics
Background
- Continuous blood sampling is essential for accurate PET/CT imaging.
- The arterial input function is critical for quantifying PET data.
- Minimizing blood loss while maintaining accuracy is a key advantage of this protocol.
- Cross-calibration of measurement devices is necessary for reliable results.
Purpose of Study
- To develop a reproducible protocol for blood sampling during imaging.
- To enhance the accuracy of biokinetic modeling through precise data collection.
- To demonstrate the procedure effectively for researchers in the field.
Methods Used
- Catheterization of the femoral vein and artery in rats.
- Use of an extracorporeal arteriovenous shunt for blood sampling.
- Integration of blood sampling with PET/CT imaging workflows.
- Data collection and analysis using well counters and online sampling software.
Main Results
- Successful placement of catheters allows for continuous blood flow measurement.
- Accurate arterial input function data is generated for subsequent analysis.
- The protocol demonstrates minimal blood loss and high temporal resolution.
- Data supports effective biokinetic modeling for PET imaging.
Conclusions
- The protocol is effective for continuous blood sampling during PET/CT imaging.
- It provides reliable data for the arterial input function.
- This method can enhance the accuracy of pharmacokinetic studies in neuroscience.
Frequently Asked Questions
What is the main advantage of this blood sampling protocol?
The protocol minimizes blood loss while providing high accuracy in measuring the arterial input function.
How is the arterial input function measured?
It is measured by collecting blood samples in parallel with PET/CT imaging using a shunt system.
What are the key steps in catheter placement?
Key steps include making an incision, ligating vessels, and carefully inserting the catheter at a 45-degree angle.
Why is cross-calibration important?
Cross-calibration ensures that all measurement devices provide accurate and consistent data for analysis.
Who demonstrates the procedure in the video?
The procedure is demonstrated by technicians Anne Moller and Joanna Forster from the laboratory.
Executive Industry Relevance
Accurate measurement of the arterial input function (AIF) is essential for quantitative PET/CT analysis in preclinical drug development, enabling precise bio-kinetic modeling of radiotracer behavior. This protocol supports target validation and lead identification by providing high-resolution, reproducible AIF data with minimal animal blood loss, improving data quality for oncology, neurodegenerative, and cardiovascular disease models. Enhanced AIF accuracy increases predictive confidence in early discovery decisions and reduces mechanistic ambiguity in translational research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through precise quantification of radiotracer availability in blood.
- Operational Value: Supports biological de-risking by generating reliable AIF data for target engagement and pathway analysis.
- Predictive Value: Improves portfolio triage by increasing confidence in early-stage target validation through standardized kinetic modeling.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream workflows by delivering consistent, high-temporal-resolution AIF measurements.
- Operational Value: Enhances assay standardization and reproducibility through cross-calibrated detection systems and controlled sampling protocols.
- Screening Readiness: Enables reliable compound evaluation by providing accurate blood radioactivity measurements for input function derivation.
Translational & Preclinical Research
- Translational Continuity: Supports disease-relevant systems by allowing AIF measurement across oncological, neurodegenerative, and myocardial models.
- Mechanistic De-risking: Facilitates risk-adjusted advancement decisions through precise tracer kinetic characterization in preclinical studies.
- Biomarker Alignment: Enables evaluation of pharmaceutical behavior for diagnostic and therapeutic approaches via accurate bio-kinetic modeling.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead identification to preclinical studies, supporting hypothesis testing and quantitative analysis in imaging-based drug discovery.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling accurate measurement of radiotracer delivery to tissues.
- Screening: Ensures assay readiness through reproducible, high-resolution blood sampling that enables reliable compound evaluation.
- Analytics: Provides quantitative dependent variable measurements (blood radioactivity over time) essential for comparing experimental conditions and modeling tracer kinetics.
- Translational Research: Connects discovery to preclinical continuity by enabling AIF measurement in disease models relevant to human pathophysiology.
- Enterprise Reuse: Establishes a reusable capability for AIF determination across radiotracers and animal models, reducing redundant method development.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in radiotracer kinetics.
- Operational Value: Delivers standardization, reproducibility, and scalability through a highly standardized workflow and cross-calibration requirements.
- Strategic Value: Improves go/no-go decisions and capital efficiency by lowering late-stage biological risk through better early-phase data quality.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement decisions via reliable AIF data supporting translational biomarker alignment.
Implementation Considerations
- Requires expertise in microsurgical techniques for femoral vessel catheterization in small animals.
- Dependent on instrumentation including peristaltic pumps, shunt systems, radioactivity detectors, and PET/CT scanners.
- Necessitates cross-team standardization between surgery, imaging, and data analysis teams for synchronized workflows.
- Involves adaptation considerations across model systems due to variations in vessel size and anatomy.
- Includes practical limitations such as the time-consuming preparation for vascular access and risk of clotting in the shunt system.
Biopharma FAQs
Why does null hypothesis testing matter for target validation?
Null hypothesis testing helps determine whether observed differences in radiotracer uptake between experimental and control groups are statistically significant, supporting confident target validation decisions in preclinical studies.
How does independent variable isolation fit the discovery pipeline?
Isolating the independent variable (e.g., drug dose or genetic modification) allows researchers to attribute changes in arterial input function or tissue uptake specifically to the intervention, improving target validation rigor.
What do quantitative dependent variable measurements enable?
Quantitative measurements of blood radioactivity over time enable precise arterial input function derivation, which is required for accurate bio-kinetic modeling and comparison of radiotracer behavior across conditions.
Why do replication requirements matter for cross-functional collaboration?
Replication ensures that arterial input function data is consistent across experiments, enabling reliable data sharing between discovery, preclinical, and translational teams for unified decision-making.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to perform background correction, decay correction, and calibration of blood radioactivity data, along with time synchronization between sampling and imaging systems for accurate temporal alignment.
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg%3Fv%3D2026-08-26T02%253A14%253A49.000Z&w=384&q=75)
